S&P 500   3,404.78 (+0.11%)
DOW   27,614.41 (-0.26%)
QQQ   282.15 (+0.60%)
AAPL   116.63 (+1.37%)
MSFT   213.05 (+1.41%)
FB   282.43 (+1.92%)
GOOGL   1,587.66 (+0.21%)
AMZN   3,269.11 (+1.94%)
TSLA   422.51 (+0.53%)
NVDA   531.24 (+1.06%)
BABA   317.71 (+3.53%)
CGC   18.73 (+1.08%)
GE   7.14 (-3.25%)
MU   51.65 (-0.94%)
AMD   77.83 (-5.35%)
T   27.06 (-1.17%)
F   7.93 (-1.25%)
ACB   4.15 (-5.68%)
GILD   59.61 (-0.58%)
NFLX   486.72 (-0.31%)
NIO   27.60 (+6.11%)
BA   157.07 (-2.34%)
DIS   123.77 (-0.23%)
S&P 500   3,404.78 (+0.11%)
DOW   27,614.41 (-0.26%)
QQQ   282.15 (+0.60%)
AAPL   116.63 (+1.37%)
MSFT   213.05 (+1.41%)
FB   282.43 (+1.92%)
GOOGL   1,587.66 (+0.21%)
AMZN   3,269.11 (+1.94%)
TSLA   422.51 (+0.53%)
NVDA   531.24 (+1.06%)
BABA   317.71 (+3.53%)
CGC   18.73 (+1.08%)
GE   7.14 (-3.25%)
MU   51.65 (-0.94%)
AMD   77.83 (-5.35%)
T   27.06 (-1.17%)
F   7.93 (-1.25%)
ACB   4.15 (-5.68%)
GILD   59.61 (-0.58%)
NFLX   486.72 (-0.31%)
NIO   27.60 (+6.11%)
BA   157.07 (-2.34%)
DIS   123.77 (-0.23%)
S&P 500   3,404.78 (+0.11%)
DOW   27,614.41 (-0.26%)
QQQ   282.15 (+0.60%)
AAPL   116.63 (+1.37%)
MSFT   213.05 (+1.41%)
FB   282.43 (+1.92%)
GOOGL   1,587.66 (+0.21%)
AMZN   3,269.11 (+1.94%)
TSLA   422.51 (+0.53%)
NVDA   531.24 (+1.06%)
BABA   317.71 (+3.53%)
CGC   18.73 (+1.08%)
GE   7.14 (-3.25%)
MU   51.65 (-0.94%)
AMD   77.83 (-5.35%)
T   27.06 (-1.17%)
F   7.93 (-1.25%)
ACB   4.15 (-5.68%)
GILD   59.61 (-0.58%)
NFLX   486.72 (-0.31%)
NIO   27.60 (+6.11%)
BA   157.07 (-2.34%)
DIS   123.77 (-0.23%)
S&P 500   3,404.78 (+0.11%)
DOW   27,614.41 (-0.26%)
QQQ   282.15 (+0.60%)
AAPL   116.63 (+1.37%)
MSFT   213.05 (+1.41%)
FB   282.43 (+1.92%)
GOOGL   1,587.66 (+0.21%)
AMZN   3,269.11 (+1.94%)
TSLA   422.51 (+0.53%)
NVDA   531.24 (+1.06%)
BABA   317.71 (+3.53%)
CGC   18.73 (+1.08%)
GE   7.14 (-3.25%)
MU   51.65 (-0.94%)
AMD   77.83 (-5.35%)
T   27.06 (-1.17%)
F   7.93 (-1.25%)
ACB   4.15 (-5.68%)
GILD   59.61 (-0.58%)
NFLX   486.72 (-0.31%)
NIO   27.60 (+6.11%)
BA   157.07 (-2.34%)
DIS   123.77 (-0.23%)
Log in
NASDAQ:CSTL

Castle Biosciences News Headlines

$51.02
+0.04 (+0.08 %)
(As of 10/27/2020 12:33 PM ET)
Add
Compare
Today's Range
$50.78
Now: $51.02▼
$51.03
50-Day Range
$48.04
MA: $50.88▼
$54.86
52-Week Range
$17.35
Now: $51.02▼
$55.31
Volume345 shs
Average Volume177,565 shs
Market Capitalization$1.00 billion
P/E Ratio463.86
Dividend YieldN/A
Beta0.39

Headlines

Castle Biosciences (NASDAQ CSTL) News Headlines Today

Source:
DateHeadline
Castle Biosciences to Release Third Quarter 2020 Financial Results and Host Conference Call on Monday, November 9, 2020Castle Biosciences to Release Third Quarter 2020 Financial Results and Host Conference Call on Monday, November 9, 2020
finance.yahoo.com - October 26 at 8:47 AM
Castle Biosciences (NASDAQ:CSTL) Shares Up 5.4%Castle Biosciences (NASDAQ:CSTL) Shares Up 5.4%
americanbankingnews.com - October 22 at 9:28 PM
Castle Biosciences (NASDAQ:CSTL) Insider Sells $49,650.00 in StockCastle Biosciences (NASDAQ:CSTL) Insider Sells $49,650.00 in Stock
americanbankingnews.com - October 22 at 8:45 PM
Insider Selling: Castle Biosciences (NASDAQ:CSTL) Director Sells 11,750 Shares of StockInsider Selling: Castle Biosciences (NASDAQ:CSTL) Director Sells 11,750 Shares of Stock
americanbankingnews.com - October 22 at 8:45 PM
Castle Biosciences to Hold Webcast for Investors Highlighting Commercial Launch of ConfirmDx®-MelanomaCastle Biosciences to Hold Webcast for Investors Highlighting Commercial Launch of ConfirmDx®-Melanoma
finance.yahoo.com - October 21 at 8:53 AM
Short Interest in Castle Biosciences (NASDAQ:CSTL) Rises By 40.3%Short Interest in Castle Biosciences (NASDAQ:CSTL) Rises By 40.3%
americanbankingnews.com - October 17 at 1:23 PM
Precigen (PGEN) Looks Good: Stock Adds 7.1% in SessionPrecigen (PGEN) Looks Good: Stock Adds 7.1% in Session
nasdaq.com - October 16 at 7:49 PM
Castle Biosciences Presents Data on DecisionDx-Melanoma at the Virtual European Association of Dermato-Oncology (EADO) CongressCastle Biosciences Presents Data on DecisionDx-Melanoma at the Virtual European Association of Dermato-Oncology (EADO) Congress
businesswire.com - October 16 at 7:00 AM
Castle Biosciences (NASDAQ:CSTL) CFO Sells $712,270.00 in StockCastle Biosciences (NASDAQ:CSTL) CFO Sells $712,270.00 in Stock
americanbankingnews.com - October 15 at 5:34 PM
Castle Biosciences (NASDAQ:CSTL) Director Joseph C. Cook III Sells 19,676 SharesCastle Biosciences (NASDAQ:CSTL) Director Joseph C. Cook III Sells 19,676 Shares
americanbankingnews.com - October 14 at 11:42 PM
Joseph C. Cook III Sells 6,475 Shares of Castle Biosciences (NASDAQ:CSTL) StockJoseph C. Cook III Sells 6,475 Shares of Castle Biosciences (NASDAQ:CSTL) Stock
americanbankingnews.com - October 14 at 11:42 PM
Castle Biosciences (NASDAQ:CSTL) Director David S. Kabakoff Sells 50,000 SharesCastle Biosciences (NASDAQ:CSTL) Director David S. Kabakoff Sells 50,000 Shares
americanbankingnews.com - October 13 at 2:14 PM
Castle Biosciences (NASDAQ:CSTL) Price Target Raised to $61.00 at Canaccord GenuityCastle Biosciences (NASDAQ:CSTL) Price Target Raised to $61.00 at Canaccord Genuity
americanbankingnews.com - October 13 at 9:29 AM
Castle Biosciences Presents Data at the 2020 American Society for Dermatologic Surgery (ASDS) Virtual Annual MeetingCastle Biosciences Presents Data at the 2020 American Society for Dermatologic Surgery (ASDS) Virtual Annual Meeting
businesswire.com - October 12 at 9:43 AM
Castle Biosciences (NASDAQ:CSTL) Expected to Announce Quarterly Sales of $15.31 MillionCastle Biosciences (NASDAQ:CSTL) Expected to Announce Quarterly Sales of $15.31 Million
americanbankingnews.com - October 9 at 5:54 AM
Castle Biosciences (NASDAQ:CSTL) Sets New 1-Year High at $54.64Castle Biosciences (NASDAQ:CSTL) Sets New 1-Year High at $54.64
americanbankingnews.com - October 8 at 12:15 PM
Castle Biosciences announces expanded medicare for DecisionDx-Melanoma in Cutaneous MelanomaCastle Biosciences announces expanded medicare for DecisionDx-Melanoma in Cutaneous Melanoma
seekingalpha.com - October 8 at 10:56 AM
Castle Biosciences (NASDAQ:CSTL) Expected to Post Earnings of -$0.06 Per ShareCastle Biosciences (NASDAQ:CSTL) Expected to Post Earnings of -$0.06 Per Share
americanbankingnews.com - October 7 at 3:16 AM
Insider Selling: Castle Biosciences (NASDAQ:CSTL) Director Sells 25,000 Shares of StockInsider Selling: Castle Biosciences (NASDAQ:CSTL) Director Sells 25,000 Shares of Stock
americanbankingnews.com - October 6 at 6:49 PM
Castle Biosciences (NASDAQ:CSTL) Director Sells $131,200.00 in StockCastle Biosciences (NASDAQ:CSTL) Director Sells $131,200.00 in Stock
americanbankingnews.com - October 5 at 6:33 PM
Castle Biosciences (NASDAQ:CSTL) Insider Sells $962,569.60 in StockCastle Biosciences (NASDAQ:CSTL) Insider Sells $962,569.60 in Stock
americanbankingnews.com - October 5 at 6:32 PM
Castle Biosciences (NASDAQ:CSTL) Hits New 52-Week High at $52.51Castle Biosciences (NASDAQ:CSTL) Hits New 52-Week High at $52.51
americanbankingnews.com - October 2 at 11:41 AM
Castle Biosciences to Present at the Baird 2020 Global Healthcare ConferenceCastle Biosciences to Present at the Baird 2020 Global Healthcare Conference
finance.yahoo.com - September 4 at 7:16 AM
Castle Biosciences Announces Commercial Launch of DecisionDx-SCCCastle Biosciences Announces Commercial Launch of DecisionDx-SCC
finance.yahoo.com - September 2 at 6:54 PM
Castle Biosciences Announces Leadership Promotions and New Medical DirectorCastle Biosciences Announces Leadership Promotions and New Medical Director
finance.yahoo.com - September 1 at 5:48 PM
Castle Biosciences to Hold Webcast Highlighting Commercial Launch of DecisionDx-SCCCastle Biosciences to Hold Webcast Highlighting Commercial Launch of DecisionDx-SCC
finance.yahoo.com - August 26 at 6:59 PM
A Closer Look At Castle Biosciences, Inc.s (NASDAQ:CSTL) Uninspiring ROEA Closer Look At Castle Biosciences, Inc.'s (NASDAQ:CSTL) Uninspiring ROE
finance.yahoo.com - August 11 at 9:00 PM
A Closer Look At Castle Biosciences, Inc.'s (NASDAQ:CSTL) Uninspiring ROEA Closer Look At Castle Biosciences, Inc.'s (NASDAQ:CSTL) Uninspiring ROE
finance.yahoo.com - August 11 at 3:59 PM
Castle Biosciences, Inc.s (CSTL) CEO Derek Maetzold on Q2 2020 Results - Earnings Call TranscriptCastle Biosciences, Inc.'s (CSTL) CEO Derek Maetzold on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 11 at 1:53 AM
Castle Biosciences, Inc. 2020 Q2 - Results - Earnings Call PresentationCastle Biosciences, Inc. 2020 Q2 - Results - Earnings Call Presentation
seekingalpha.com - August 10 at 8:50 PM
Castle Biosciences EPS beats by $0.32, beats on revenueCastle Biosciences EPS beats by $0.32, beats on revenue
seekingalpha.com - August 10 at 8:50 PM
Castle Biosciences Announces Second Quarter 2020 ResultsCastle Biosciences Announces Second Quarter 2020 Results
finance.yahoo.com - August 10 at 8:50 PM
Castle Biosciences, Inc. (CSTL) Reports Q2 Loss, Tops Revenue EstimatesCastle Biosciences, Inc. (CSTL) Reports Q2 Loss, Tops Revenue Estimates
finance.yahoo.com - August 10 at 8:50 PM
Castle Biosciences to Present at the Canaccord Genuity 40th Annual Growth ConferenceCastle Biosciences to Present at the Canaccord Genuity 40th Annual Growth Conference
businesswire.com - August 5 at 7:31 AM
Castle Biosciences, Inc. (CSTL) May Report Negative Earnings: Know the Trend Ahead of Next Weeks ReleaseCastle Biosciences, Inc. (CSTL) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
finance.yahoo.com - August 3 at 10:29 PM
Castle Biosciences, Inc. (CSTL) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseCastle Biosciences, Inc. (CSTL) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
finance.yahoo.com - August 3 at 5:29 PM
Castle Biosciences to Release Second Quarter 2020 Financial Results and Host Conference Call on Monday, August 10, 2020Castle Biosciences to Release Second Quarter 2020 Financial Results and Host Conference Call on Monday, August 10, 2020
finance.yahoo.com - July 27 at 9:49 AM
Castle Biosciences Announces Publication of Clinical Utility, Long-Term Outcomes Data and Meta-Analysis for DecisionDx-UM for Patients with Uveal MelanomaCastle Biosciences Announces Publication of Clinical Utility, Long-Term Outcomes Data and Meta-Analysis for DecisionDx-UM for Patients with Uveal Melanoma
finance.yahoo.com - July 15 at 1:14 PM
Second Systematic Review and Meta-Analysis Published Demonstrating DecisionDx-Melanoma as Independent Predictor of Recurrence, Distant Metastasis and Overall Survival in ...Second Systematic Review and Meta-Analysis Published Demonstrating DecisionDx-Melanoma as Independent Predictor of Recurrence, Distant Metastasis and Overall Survival in ...
www.businesswire.com - July 9 at 2:19 PM
Second Systematic Review and Meta-Analysis Published Demonstrating DecisionDx-Melanoma as Independent Predictor of Recurrence, Distant Metastasis and Overall Survival in Cutaneous MelanomaSecond Systematic Review and Meta-Analysis Published Demonstrating DecisionDx-Melanoma as Independent Predictor of Recurrence, Distant Metastasis and Overall Survival in Cutaneous Melanoma
finance.yahoo.com - July 9 at 8:25 AM
Castle Biosciences Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares of Common StockCastle Biosciences Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares of Common Stock
finance.yahoo.com - July 2 at 6:58 PM
Hedge Funds Are Betting On Castle Biosciences, Inc. (CSTL)Hedge Funds Are Betting On Castle Biosciences, Inc. (CSTL)
finance.yahoo.com - June 26 at 1:23 PM
Castle Bio prices equity offering at $37Castle Bio prices equity offering at $37
seekingalpha.com - June 25 at 8:00 AM
Castle Biosciences Announces Pricing of $74.0 Million Public Offering of Common StockCastle Biosciences Announces Pricing of $74.0 Million Public Offering of Common Stock
www.businesswire.com - June 24 at 9:54 PM
BRIEF-Castle Biosciences Files For Offering Of 1.5 Mln SharesBRIEF-Castle Biosciences Files For Offering Of 1.5 Mln Shares
www.reuters.com - June 22 at 11:05 PM
Castle Biosciences readies 1.5M-share equity offeringCastle Biosciences readies 1.5M-share equity offering
seekingalpha.com - June 22 at 6:05 PM
Castle Biosciences Announces Proposed Underwritten Public Offering of Common StockCastle Biosciences Announces Proposed Underwritten Public Offering of Common Stock
www.businesswire.com - June 22 at 4:55 PM
Castle Biosciences Announces Change of Location of Annual Meeting of Stockholders to Be Held June 4, 2020Castle Biosciences Announces Change of Location of Annual Meeting of Stockholders to Be Held June 4, 2020
finance.yahoo.com - May 22 at 9:13 AM
Castle Bisociences Grows Despite Covid19 DampingCastle Bisociences Grows Despite Covid19 Damping
seekingalpha.com - May 21 at 6:40 PM
Post-IPO Review: Castle Biosciences Grows Despite Pandemics EffectsPost-IPO Review: Castle Biosciences Grows Despite Pandemic's Effects
www.thestreet.com - May 21 at 6:40 PM
This page was last updated on 10/27/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.